|
1
|
Llovet JM, Kelley RK, Villanueva A, Singal
AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and
Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cree IA, Indave Ruiz BI, Zavadil J, McKay
J, Olivier M, Kozlakidis Z, Lazar AJ, Hyde C, Holdenrieder S,
Hastings R, et al: The international collaboration for cancer
classification and research. Int J Cancer. 148:560–571. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanwal F, Kramer J, Asch SM, Chayanupatkul
M, Cao Y and El-Serag HB: Risk of hepatocellular cancer in HCV
patients treated with direct-acting antiviral agents.
Gastroenterology. 153:996–1005.e1. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Estes C, Razavi H, Loomba R, Younossi Z
and Sanyal AJ: Modeling the epidemic of nonalcoholic fatty liver
disease demonstrates an exponential increase in burden of disease.
Hepatology. 67:123–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
European Association for the Study of the
Liver, . Electronic address simpleeasloffice@easloffice.eu.
European Association for the Study of the Liver: EASL clinical
practice guidelines: Management of hepatocellular carcinoma. J
Hepatol. 69:182–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
Chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abbastabar M, Sarfi M, Golestani A and
Khalili E: lncRNA involvement in hepatocellular carcinoma
metastasis and prognosis. EXCLI J. 17:900–913. 2018.PubMed/NCBI
|
|
8
|
White EK, Moore-Jarrett T and Ruley HE:
PUM2, a novel murine puf protein, and its consensus RNA-binding
site. RNA. 7:1855–1866. 2001.PubMed/NCBI
|
|
9
|
Fox M, Urano J and Reijo Pera RA:
Identification and characterization of RNA sequences to which human
PUMILIO-2 (PUM2) and deleted in Azoospermia-like (DAZL) bind.
Genomics. 85:92–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao Y, Liu C, Wang Q, Wang W, Tao E and
Wan L: Pum2 mediates Sirt1 mRNA decay and exacerbates
hypoxia/reoxygenation-induced cardiomyocyte apoptosis. Exp Cell
Res. 393:1120582020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smialek MJ, Kuczynska B, Ilaslan E,
Janecki DM, Sajek MP, Kusz-Zamelczyk K and Jaruzelska J: Kinesin
KIF18A is a novel PUM-regulated target promoting mitotic
progression and survival of a human male germ cell line. J Cell
Sci. 133:jcs2409862020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu R, Zhu X, Chen C, Xu R, Li Y and Xu W:
RNA-binding protein PUM2 suppresses osteosarcoma progression via
partly and competitively binding to STARD13 3′UTR with miRNAs. Cell
Prolif. 51:e125082018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao W, Ma J, Zheng J, Liu X, Liu Y, Ruan
X, Shen S, Shao L, Chen J and Xue Y: Silencing SCAMP1-TV2 inhibited
the malignant biological behaviors of breast cancer cells by
interaction with PUM2 to facilitate INSM1 mRNA degradation. Front
Oncol. 10:6132020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Sun W, Yang J, Yang L, Li C, Liu
H, Liu X and Jiao B: PUM2 promotes glioblastoma cell proliferation
and migration via repressing BTG1 expression. Cell Struct Funct.
44:29–39. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res.
45:(W1)W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:(Database Issue). D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muppirala UK, Honavar VG and Dobbs D:
Predicting RNA-protein interactions using only sequence
information. BMC Bioinformatics. 12:4892011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao Y, Ren Y, Ma H, Zhou C, Liu J, Shi Q,
Feng G, Zheng C and Xiong B: Classification of hepatocellular
carcinoma diameter by statistical technology and prognostic
evaluation in patients after the combined use of transarterial
chemoembolization and radiofrequency ablation. J Cancer Res Ther.
16:356–364. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang W and Wei C: Advances in the early
diagnosis of hepatocellular carcinoma. Genes Dis. 7:308–319. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim DW, Talati C and Kim R: Hepatocellular
carcinoma (HCC): Beyond sorafenib-chemotherapy. J Gastrointest
Oncol. 8:256–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ichikawa T, Sano K and Morisaka H:
Diagnosis of pathologically early HCC with EOB-MRI: Experiences and
current consensus. Liver Cancer. 3:97–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gentile D, Donadon M, Lleo A, Aghemo A,
Roncalli M, di Tommaso L and Torzilli G: Surgical treatment of
hepatocholangiocarcinoma: A systematic review. Liver Cancer.
9:15–27. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gennarino VA, Singh RK, White JJ, De Maio
A, Han K, Kim JY, Jafar-Nejad P, di Ronza A, Kang H, Sayegh LS, et
al: Pumilio1 haploinsufficiency leads to SCA1-like
neurodegeneration by increasing wild-type Ataxin1 levels. Cell.
160:1087–1098. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen D, Zheng W, Lin A, Uyhazi K, Zhao H
and Lin H: Pumilio 1 suppresses multiple activators of p53 to
safeguard spermatogenesis. Curr Biol. 22:420–425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Crittenden SL, Bernstein DS, Bachorik JL,
Thompson BE, Gallegos M, Petcherski AG, Moulder G, Barstead R,
Wickens M and Kimble J: A conserved RNA-binding protein controls
germline stem cells in Caenorhabditis elegans. Nature. 417:660–663.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nishanth MJ and Simon B: Functions,
mechanisms and regulation of Pumilio/Puf family RNA binding
proteins: A comprehensive review. Mol Biol Rep. 47:785–807. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moore FL, Jaruzelska J, Fox MS, Urano J,
Firpo MT, Turek PJ, Dorfman DM and Pera RA: Human Pumilio-2 is
expressed in embryonic stem cells and germ cells and interacts with
DAZ (Deleted in AZoospermia) and DAZ-like proteins. Proc Natl Acad
Sci USA. 100:538–543. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shigunov P, Sotelo-Silveira J, Kuligovski
C, de Aguiar AM, Rebelatto CK, Moutinho JA, Brofman PS, Krieger MA,
Goldenberg S, Munroe D, et al: PUMILIO-2 is involved in the
positive regulation of cellular proliferation in human
adipose-derived stem cells. Stem Cells Dev. 21:217–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee MH, Wu X and Zhu Y: RNA-binding
protein PUM2 regulates mesenchymal stem cell fate via repression of
JAK2 and RUNX2 mRNAs. J Cell Physiol. 235:3874–3885. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Duan W, Nian L, Qiao J and Liu NN: LncRNA
TUG1 aggravates the progression of cervical cancer by binding PUM2.
Eur Rev Med Pharmacol Sci. 23:8211–8218. 2019.PubMed/NCBI
|
|
35
|
Matsuda S, Rouault J, Magaud J and Berthet
C: In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS
Lett. 497:67–72. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoneda M, Suzuki T, Nakamura T, Ajima R,
Yoshida Y, Kakuta S, Katsuko S, Iwakura Y, Shibutani M, Mitsumori
K, et al: Deficiency of antiproliferative family protein Ana
correlates with development of lung adenocarcinoma. Cancer Sci.
100:225–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamamoto N, Uzawa K, Yakushiji T,
Shibahara T, Noma H and Tanzawa H: Analysis of the ANA gene as a
candidate for the chromosome 21q oral cancer susceptibility locus.
Br J Cancer. 84:754–759. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu L, Liu S, Duan Q, Chen L, Wu T, Qian
H, Yang S, Xin D, He Z and Guo Y: MicroRNA-142-5p promotes cell
growth and migration in renal cell carcinoma by targeting BTG3. Am
J Transl Res. 9:2394–2402. 2017.PubMed/NCBI
|
|
39
|
Ren XL, Zhu XH, Li XM, Li YL, Wang JM, Wu
PX, Lv ZB, Ma WH, Liao WT, Wang W, et al: Down-regulation of BTG3
promotes cell proliferation, migration and invasion and predicts
survival in gastric cancer. J Cancer Res Clin Oncol. 141:397–405.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang L, Mo H, Jiang Y, Wang Y, Sun L, Yao
B, Chen T, Liu R, Li Q, Liu Q and Yin G: MicroRNA-519c-3p promotes
tumor growth and metastasis of hepatocellular carcinoma by
targeting BTG3. Biomed Pharmacother. 118:1092672019. View Article : Google Scholar : PubMed/NCBI
|
